Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: SER – AMEX
Animal Usage: Animal Testing
Serina Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company confirms in the following report that they exploit animals for product testing.
“We entered into a Sponsored Research Agreement with Ohio State University using AGEX-BAT1 in mice to determine whether transplantation of AgeX-BAT1 cells may lead to improvements in diet-induced obesity, metabolic health including glucose metabolism, and cardiac function.” (Page 14) Read the full document
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Company Website: https://www.serinatherapeutics.com